These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2669222)

  • 1. Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease.
    Young IH; Daviskas E; Keena VA
    Thorax; 1989 May; 44(5):387-90. PubMed ID: 2669222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease.
    Leung R; Hill P; Burdon J
    Thorax; 1996 Jun; 51(6):596-600. PubMed ID: 8693440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of high doses of inhaled morphine on exercise endurance in chronic obstructive pulmonary disease.
    Jankelson D; Hosseini K; Mather LE; Seale JP; Young IH
    Eur Respir J; 1997 Oct; 10(10):2270-4. PubMed ID: 9387952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease.
    Masood AR; Reed JW; Thomas SH
    Thorax; 1995 Jun; 50(6):629-34. PubMed ID: 7638804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
    Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
    Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
    O'Donnell DE; Lam M; Webb KA
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine.
    Noseda A; Carpiaux JP; Markstein C; Meyvaert A; de Maertelaer V
    Eur Respir J; 1997 May; 10(5):1079-83. PubMed ID: 9163650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient.
    Beauford W; Saylor TT; Stansbury DW; Avalos K; Light RW
    Chest; 1993 Jul; 104(1):175-8. PubMed ID: 8325064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulised morphine for severe interstitial lung disease.
    Polosa R; Simidchiev A; Walters EH
    Cochrane Database Syst Rev; 2002; 2002(3):CD002872. PubMed ID: 12137662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dyspnea and morphine aerosols in the palliative care of lung cancer].
    Grimbert D; Lubin O; de Monte M; Vecellio None L; Perrier M; Carré P; Lemarié E; Boissinot E; Diot P
    Rev Mal Respir; 2004 Dec; 21(6 Pt 1):1091-7. PubMed ID: 15767953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute respiratory depression as a complication of nebulised morphine.
    Lang E; Jedeikin R
    Can J Anaesth; 1998 Jan; 45(1):60-2. PubMed ID: 9466030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial.
    Abdallah SJ; Wilkinson-Maitland C; Saad N; Li PZ; Smith BM; Bourbeau J; Jensen D
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
    Aliverti A; Rodger K; Dellacà RL; Stevenson N; Lo Mauro A; Pedotti A; Calverley PM
    Thorax; 2005 Nov; 60(11):916-24. PubMed ID: 15994253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled furosemide for relief of air hunger versus sense of breathing effort: a randomized controlled trial.
    Grogono JC; Butler C; Izadi H; Moosavi SH
    Respir Res; 2018 Sep; 19(1):181. PubMed ID: 30236110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of formoterol inhalation on endurance performance in hypobaric conditions.
    Riiser A; Tjørhom A; Carlsen KH
    Med Sci Sports Exerc; 2006 Dec; 38(12):2132-7. PubMed ID: 17146320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.
    Jensen D; Alsuhail A; Viola R; Dudgeon DJ; Webb KA; O'Donnell DE
    J Pain Symptom Manage; 2012 Apr; 43(4):706-19. PubMed ID: 22168961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.
    Oga T; Nishimura K; Tsukino M; Hajiro T; Ikeda A; Izumi T
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1897-901. PubMed ID: 10852763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2000; (2):CD001506. PubMed ID: 10796798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.